Latest move to cut funding for vaccines is not down to US health secretary. It is part of Trump’s wider war on science.

With a 5.98% market share, India is the fourth-largest pharmaceutical supplier to the U.S., behind Ireland, Switzerland, and ...

An official overseeing implementation of the Make America Healthy Again agenda at the Department of Health and Human Services ...

Last week, President Trump sent letters to 17 major pharmaceutical companies advising them to work with his administration to ...

SERB Pharmaceuticals plans to buy Y-mAbs Pharmaceuticals in a $412 million all-cash deal. CorMedix bought Melinta ...

US Health Secretary Robert F. Kennedy Jr. has slashed government spending on mRNA vaccine research. Experts warn it will boost global vulnerability to future pandemics.

CSL Seqirus was one of the drugmakers the federal government listed this week as having its mRNA-related work cut. In an ...

The U.S. government has been discussing with drugmakers how to raise overseas drug prices as President Donald Trump seeks to implement his Most Favored Nation policy, which attempts to lower U.S. drug ...

Health Secretary Robert F. Kennedy Jr.'s decision this week to cancel hundreds of millions of dollars in mRNA vaccine funding ...

The FTSE 100 edged down on Friday on a mixed day for European equities despite new optimism about an end to the war between ...